Characterisation of lung immune cells in health and disease

  • Research type

    Research Study

  • Full title

    Characterisation of lung immune cells in health and disease

  • IRAS ID

    168772

  • Contact name

    Mahdad Noursadeghi

  • Contact email

    m.noursadeghi@ucl.ac.uk

  • Sponsor organisation

    University College London

  • Clinicaltrials.gov Identifier

    Z6364106/2015/03/07, UCL Data Protection

  • Duration of Study in the UK

    2 years, 8 months, 1 days

  • Research summary

    Respiratory conditions are a significant cause of disease worldwide. These include viral, bacterial and fungal respiratory tract infections, a wide range of primary or interstitial lung diseases, obstructive airway diseases as a consequence of asthma, smoking or bronchiectasis, and lung cancer. In order to improve our understanding of these diseases, it is essential to obtain immune cells from the lung by bronchoscopy. Bronchoscopy is routinely carried out for the investigation of respiratory diseases. Bronchoalveolar lavage (BAL) fluid is taken as a routine part of the bronchoscopy and contains lung immune cells.

    In the lung, alveolar macrophages are found in the air spaces known as alveoli. Alveolar macrophages are more abundant than any other immune cells at this site. Inflammation at the site of infection principally arises from initial immune responses by these resident macrophages and another type of immune cell, dendritic cells. It is therefore essential to obtain genuine alveolar macrophages to study their normal immunological functions and dysfunctions in disease states. This will contribute to our understanding of the pathogenesis of respiratory disease and may lead to the development of novel therapeutics.

    BAL also contains lymphocytes which are important immune cells that can interact with macrophages both directly and indirectly through cytokine (proteins important in cell signalling) networks. Therefore, the use of BAL to obtain alveolar macrophages has the additional advantage of providing lymphocytes and lavage fluid cytokines which are present as a result of any in vivo (within patient) immune responses that are taking place in the lung at the time of sampling.

  • REC name

    East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

  • REC reference

    15/EE/0138

  • Date of REC Opinion

    26 Mar 2015

  • REC opinion

    Favourable Opinion